Adenofibroma

01/01/1985 - "The technical details of a cytochemical method for estrogen receptor identification in mammary tumours are presented and applied in 19 carcinomas and six adenofibromas. "
05/01/2007 - "This case indicates that in addition to stromal tumors, such as granulosa cell tumors, theca cell tumors, adenofibroma and so on, malignant epithelial tumors with a functioning stroma should also be considered when evaluating ovarian tumors with estrogen production in the elderly."
02/01/1940 - "This study reports on an experiment involving normal female rats, castrates of both sexes, and estrogen-injected castrates to determine whether or not estrogenic hormones are capable of influencing transplanted adenofibroma. "

02/01/1940 - " The stimulatory effect of estrogenic hormone upon mammary adenofibroma is probably exerted indirectly through the "mammogenic hormone" of the anterior pituitary. "
02/01/1940 - " Estrogenic hormone is the important endocrine factor determining the successful transplantation of mammary adenofibroma in rats. "
02/01/1940 - "This study reports on an experiment involving normal female rats, castrates of both sexes, and estrogen-injected castrates to determine whether or not estrogenic hormones are capable of influencing transplanted adenofibroma. "
08/01/2006 - "Topics such as endometritis, endometrial polyps, changes that are induced by hormones and tamoxifen within the endometrium, endometrial metaplasias and hyperplasias, atypical polypoid adenomyoma, adenofibroma, adenosarcoma, histological types of endometrial carcinoma and grading of endometrial carcinomas are discussed with regard to endometrial biopsy specimens rather than hysterectomy specimens. "

07/15/1981 - "Adenofibroma and adenosarcoma of the uterus: a clinicopathologic study of 35 cases."
02/01/1995 - "[Adenofibroma and adenosarcoma of the uterus in young women]."
02/01/1995 - "Curettage and biopsy revealed an adenofibroma of the uterus in case 1 (31 yrs) and an uterine adenosarcoma in case 2 (30 yrs). "

07/01/2006 - "This report describes the MR findings of adenofibroma and ESS associated with tamoxifen therapy. "
07/01/2006 - "Tamoxifen therapy may result in a variety of endometrial proliferative lesions, including adenofibroma and endometrial stromal sarcoma (ESS). "
07/01/2006 - "Uterine adenofibroma and endometrial stromal sarcoma associated with tamoxifen therapy: MR findings."
09/01/2002 - "Adenofibroma of the endometrium after tamoxifen therapy for breast cancer: MR findings."
05/01/1996 - "Sonographic characteristics of adenofibroma of the endometrium following tamoxifen therapy for breast cancer: two case reports."

10/01/1997 - "Benign tumours are subclassified into metanephric adenoma and adenofibroma, papillary renal cell adenoma, and renal oncocytoma. "
01/01/2002 - "Benign neoplasms are papillary adenoma, renal oncocytoma and metanephric nephroadenoma/adenofibroma. "
12/01/2001 - "The development of consensus classifications for renal epithelial neoplasia in 1996 and 1997 led to the recognition of renal adenoma, renal oncocytoma and metanephric adenoma/adenofibroma as benign tumors and conventional (clear cell) renal cell carcinoma (RCC), papillary RCC, chromophobe RCC and collecting duct carcinoma as malignant morphotypes. "
01/01/2000 - "Some of these tumors, as their names imply, are unique to the kidney, e.g., renal adenoma, metanephric adenoma, renal oncocytoma, nephrogenic adenofibroma, mesoblastic nephroma, capsuloma, juxtaglomerular cell tumor, renomedullary interstitial cell tumor (medullary fibroma), cystic nephroma, cystic partially differentiated nephroblastoma, and cystic hamartoma of the renal pelvis, while others, such as angiomyolipoma, leiomyoma, hemangioma, lipoma, etc., are not unique to the kidney and show similar morphologic features in the other sites they affect. "

07/01/2001 - "Blood samples from 63 breast cancer patients obtained at various stages of their disease, blood samples from 8 breast hyperplasia, 5 breast adenofibroma, 25 other cancers (stomach, colon, esophagus, lung, ovary) and 31 healthy volunteers were screened for hMAM mRNA by a nested RT-PCR combined with fluorescence quantitative PCR (FQ-PCR) assay. "
12/01/1994 - "Benign lesions (endometrial polyps) contained little TNF-alpha mRNA or protein, whereas specific message was abundant in proliferative lesions (hyperplasia, adenofibroma). "

01/01/1979 - "23 women with benign breast disease (fibrocystic disease or fibroadenosis) were treated for three months consecutively with a prolactin inhibitor drug, bromocriptine, at the dose of 2.5 mg every eight hours. "
11/17/1979 - "The Authors have treated 11 patients with benign breast diseases (fibroadenosis or fibrocystic disease) with two prolactin inhibitor drugs -- metergoline and bromocriptine -- at the dose of 8 mg/die and 7,5 mg/die respectively for sixty days with a 30 days interval from one to the other. "

04/01/2012 - "A total of 42 clear-cell carcinoma cases with adjacent putative precursor lesions (endometriosis-associated carcinoma cases (n=28) and (clear-cell) adenofibroma-associated carcinoma cases (n=14)) were selected and subjected to immunohistochemical analysis for ARID1A protein expression and direct genomic DNA sequencing of exons 9 and 20 of the PIK3CA gene. "
11/01/1996 - "We have used nested reverse transcription-PCR (RT-PCR) and PCR on genomic DNA to search for aberrations in the FHIT and PTPRG genes, both located in chromosomal band 3p14.2, in specimens from cytogenetically analyzed benign breast lesions (three samples with atypical hyperplasia and one with fibroadenosis) from two women belonging to breast cancer families. "

01/01/1986 - "Intraperitoneally injected 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (MTIC), a metabolite of dacarbazine, induced a high incidence of mammary adenofibromas and a low incidence of uterine leiomyosarcomas. "
04/01/1975 - "These data also indicate that MTIC is involved in the induction of mammary adenofibromas and uterine leiomyosarcomas by DTIC."

01/01/1979 - "23 women with benign breast disease (fibrocystic disease or fibroadenosis) were treated for three months consecutively with a prolactin inhibitor drug, bromocriptine, at the dose of 2.5 mg every eight hours. "
11/17/1979 - "The Authors have treated 11 patients with benign breast diseases (fibroadenosis or fibrocystic disease) with two prolactin inhibitor drugs -- metergoline and bromocriptine -- at the dose of 8 mg/die and 7,5 mg/die respectively for sixty days with a 30 days interval from one to the other. "

01/01/2015 - "Nephrectomy was performed for the patient; final histopathologic evaluation was that of a metanephric adenofibroma. "
08/01/2010 - "Metanephric adenofibroma: robotic partial nephrectomy of a large Wilms' tumor variant."
04/01/2013 - "Partial nephrectomy revealed metanephric adenofibroma, a benign stromal-epithelial tumor thought to represent a hyperdifferentiated, mature form of Wilms' tumor. "
04/01/1992 - "Nephrogenic adenofibroma is a novel kidney tumor of young people (mean age of presentation, 13 years), who present with polycythemia, hypertension, or hematuria, which resolve following nephrectomy. "

03/01/1992 - "Poor prognosis of malignant variants of mixed mesodermal tumours and their difficult differentiation from adenofibromas require close collaboration of pathologists and gynaecologists, implicating hysterectomy as proposed treatment and permanent clinical monitoring."
06/01/1990 - "Since uterine adenofibroma usually occurs in older patients, the standard treatment has been hysterectomy. "
06/01/1990 - "A hysterectomy was done 9 months later, and a polypoid lesion was noted in the fundus of the uterus which on histologic examination was thought to be potentially either an adenofibroma precursor or a maturation of the previous cellular adenofibroma. "
08/01/2006 - "Topics such as endometritis, endometrial polyps, changes that are induced by hormones and tamoxifen within the endometrium, endometrial metaplasias and hyperplasias, atypical polypoid adenomyoma, adenofibroma, adenosarcoma, histological types of endometrial carcinoma and grading of endometrial carcinomas are discussed with regard to endometrial biopsy specimens rather than hysterectomy specimens. "

03/01/2013 - "Ovarian benign clear cell adenofibroma in a patient with premature ovarian failure after 8-year hormone replacement therapy."

01/01/1990 - " Estrogen replacement is especially contraindicated for these women because it will cause fibroadenosis in the upper outer quadrant, retard the process of fatty degeneration of breast tissue, and increase the woman's chances of more cysts, more biopsies, and more anxiety as future mammograms become increasingly difficult to interpret."

01/01/2012 - "Bilateral juvenile fibroadenosis of the breast: management with subcutaneous mastectomy and silicone implant placement."